Lu AG13909

DRUG2 trials

Sponsors

H. Lundbeck A/S

Conditions

Congenital Adrenal HyperplasiaCushing's Disease

Phase 1

A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia

RecruitingNCT05669950

H. Lundbeck A/SCongenital Adrenal Hyperplasia

Start: 2022-12-19End: 2027-12-31Target: 42Updated: 2026-03-09

Phase 2

A Trial of Lu AG13909 in Adult Participants With Cushing's Disease

RecruitingNCT06471829

H. Lundbeck A/SCushing's Disease

Start: 2024-06-19End: 2027-10-31Target: 18Updated: 2026-08-21

Related Papers

MON-468 A Novel Anti-ACTH Antibody Lu AG13909 in Clinical Development for Treatment of Classic Congenital Adrenal Hyperplasia: A Phase 1 Open-Label, Multiple-Ascending-Dose Study

Journal of the Endocrine Society2025-10-011 citations

SAT-455 A Phase 2, Open-Label Trial Evaluating the Efficacy and Safety of Anti-ACTH Antibody Lu AG13909 in Adults With Classic Congenital Adrenal Hyperplasia: Trial Design

Journal of the Endocrine Society2025-10-01